GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $175,115,836,000 | +0.6% | 4,022,877 | +0.7% | 0.27% | +16.7% |
Q1 2022 | $174,067,372,000 | +2.0% | 3,996,037 | +3.3% | 0.23% | -3.7% |
Q4 2021 | $170,673,747,000 | -25.6% | 3,870,153 | -35.6% | 0.24% | -25.2% |
Q3 2021 | $229,454,451,000 | -4.1% | 6,005,089 | -0.1% | 0.32% | +2.5% |
Q2 2021 | $239,367,179,000 | +51594.5% | 6,011,230 | +46232.9% | 0.32% | +31600.0% |
Q1 2021 | $463,042,000 | -73.7% | 12,974 | -72.8% | 0.00% | -66.7% |
Q4 2020 | $1,757,899,000 | +405.2% | 47,769 | +416.8% | 0.00% | – |
Q3 2020 | $347,944,000 | -11.8% | 9,244 | -4.4% | 0.00% | -100.0% |
Q2 2020 | $394,358,000 | +42.0% | 9,668 | +31.9% | 0.00% | 0.0% |
Q1 2020 | $277,658,000 | -84.5% | 7,328 | -80.8% | 0.00% | -66.7% |
Q4 2019 | $1,794,783,000 | -50.4% | 38,195 | -54.9% | 0.00% | -50.0% |
Q3 2019 | $3,615,380,000 | +26.4% | 84,709 | +18.5% | 0.01% | 0.0% |
Q2 2019 | $2,860,109,000 | -8.9% | 71,467 | -4.9% | 0.01% | -14.3% |
Q1 2019 | $3,140,351,000 | +169.8% | 75,146 | +146.7% | 0.01% | +133.3% |
Q4 2018 | $1,163,838,000 | -39.8% | 30,459 | -36.7% | 0.00% | 0.0% |
Q3 2018 | $1,931,976,000 | +6.6% | 48,095 | +7.0% | 0.00% | 0.0% |
Q2 2018 | $1,812,499,000 | -13.5% | 44,964 | -16.2% | 0.00% | -25.0% |
Q1 2018 | $2,095,793,000 | -7.9% | 53,642 | -16.3% | 0.00% | 0.0% |
Q4 2017 | $2,274,407,000 | -45.3% | 64,122 | -37.3% | 0.00% | -60.0% |
Q3 2017 | $4,154,638,000 | -9.2% | 102,331 | -3.6% | 0.01% | -28.6% |
Q2 2017 | $4,576,455,000 | -5.1% | 106,133 | -7.2% | 0.01% | +7.7% |
Q1 2017 | $4,824,327,000 | +29.4% | 114,429 | +18.2% | 0.01% | -23.5% |
Q4 2016 | $3,727,652,000 | -44.8% | 96,797 | -38.2% | 0.02% | -39.3% |
Q3 2016 | $6,754,244,000 | +9.6% | 156,602 | +10.1% | 0.03% | 0.0% |
Q2 2016 | $6,164,422,000 | +9.2% | 142,234 | +2.2% | 0.03% | +16.7% |
Q1 2016 | $5,643,060,000 | +26.1% | 139,163 | +25.5% | 0.02% | +118.2% |
Q4 2015 | $4,474,330,000 | +20.0% | 110,888 | +14.3% | 0.01% | +22.2% |
Q3 2015 | $3,729,804,000 | -50.1% | 97,004 | -46.0% | 0.01% | -57.1% |
Q2 2015 | $7,477,466,000 | +179.1% | 179,531 | +209.3% | 0.02% | +200.0% |
Q1 2015 | $2,678,731,000 | -38.2% | 58,044 | -42.7% | 0.01% | -53.3% |
Q4 2014 | $4,333,024,000 | -6.9% | 101,381 | +0.4% | 0.02% | +275.0% |
Q3 2014 | $4,653,758,000 | +665.6% | 100,968 | +758.2% | 0.00% | +300.0% |
Q2 2014 | $607,878,000 | -8.5% | 11,765 | -2.0% | 0.00% | 0.0% |
Q1 2014 | $664,661,000 | +16.9% | 12,004 | +12.8% | 0.00% | – |
Q4 2013 | $568,390,000 | -97.8% | 10,646 | -98.0% | 0.00% | -100.0% |
Q3 2013 | $26,270,800,000 | +7871.7% | 523,635 | +7839.9% | 0.02% | – |
Q2 2013 | $329,552,000 | – | 6,595 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |